Current Document Type: HighlightsVideoPage COVID-19 in Patients With Hematologic Malignancies - JADPRO

Watch More Highlights

Sandra Kurtin, PhD, ANP-C, AOCN, of The University of Arizona Cancer Center, discusses the challenges for advanced practitioners treating patients with hematologic malignancies who are at high risk for COVID-19 infection. However, the ability to successfully detect SARS-CoV-2 in these patients remains unknown, with a strikingly high false-negative rate, and data regarding their clinical course, treatment, and outcomes is sparse (Abstract 313).

Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.